{
    "paper_id": "d4cabddf62ffb457d267c77bf7aa0b27e69027dd",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": " 49, 84, 99, 205, 223, 244, 259, 281, 321, 327, 358 ",
            "cite_spans": [
                {
                    "start": 1,
                    "end": 4,
                    "text": "49,",
                    "ref_id": null
                },
                {
                    "start": 5,
                    "end": 8,
                    "text": "84,",
                    "ref_id": null
                },
                {
                    "start": 9,
                    "end": 12,
                    "text": "99,",
                    "ref_id": null
                },
                {
                    "start": 13,
                    "end": 17,
                    "text": "205,",
                    "ref_id": null
                },
                {
                    "start": 18,
                    "end": 22,
                    "text": "223,",
                    "ref_id": null
                },
                {
                    "start": 23,
                    "end": 27,
                    "text": "244,",
                    "ref_id": null
                },
                {
                    "start": 28,
                    "end": 32,
                    "text": "259,",
                    "ref_id": null
                },
                {
                    "start": 33,
                    "end": 37,
                    "text": "281,",
                    "ref_id": null
                },
                {
                    "start": 38,
                    "end": 42,
                    "text": "321,",
                    "ref_id": null
                },
                {
                    "start": 43,
                    "end": 47,
                    "text": "327,",
                    "ref_id": null
                },
                {
                    "start": 48,
                    "end": 51,
                    "text": "358",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Rectum associated lymphoid tissue (RALT), 359 Refractive index",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Regenerative medicine",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Respiratory syncytial virus (RSV), 207, 383 Respiratory tract mucosal surface",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Retinoic-acid inducible gene (RIG), 189 gene 1 (RIG-I) receptors",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Reverse phase evaporation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Retinoic-acid inducible gene (RIG) RIG-1-like helicases (RLHs)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Rig",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "RNA-dependent RNA polymerase (RdRp)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Reactive oxygen species (ROS)",
            "authors": [
                {
                    "first": "Ros",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Respiratory syncytial virus (RSV) Rubella",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Rsv",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF1": {
            "text": "See Diphtheria toxoid (DT) DTH. See Delayed-type hypersensitivity (DTH) DTP. See Diphtheria-tetanus-pertussis (DTP) Dual biosensor principle, 29 Licensed vaccine types for use in humans, 51 Lipidated formulations targeting TLR2, 248 Lipid-based formulations, 31 Lipid-based nanostructures, 241 Lipid core peptides (LCP), 248 Lipid-covered NPs, 242 Lipid-covered particles, 243 Lipid-like self-assembling adjuvant particles, 134 See Multiple antigen peptide (MAP) Market authorization applications (MAAs), 397 Mast cells, 69 MD. See Molecular dynamics (MD) MDDCs. See Myeloid-derived dendritic cells TAAs. See Tumor-associated antigens (TAAs) TAMs. See Tumor-associated macrophages (TAMs) Targeted patient population, 400 T cells, 49, 84, 259, 280, 286 Telomerase, 28, 29 TEM. See Transmission electron microscopy (TEM) Template-assisted synthesis, 3 Temporal evolution, 1 TEMs. See Tie2 expressing monocytes (TEMs) Terminal bronchioles, 358 Tetanus toxoid (TT), 155, 295 Tetanus vaccine, 83 Th1 and Th2 cells, 243 Th1 cell-derived cytokines, 245 Th2 cells, activation of, 245 Th1 cytokines, 246 Th2 cytokines, 245 T helper cells (Th cells), 49 Therapeutic nanoparticles, 30 Therapeutic vaccines, 171 Th1 immune responses, 86, 246 Th1 immunomodulation, 292 Thin film optical filters, 11 Th1-mediated responses, 244 Tie2 expressing monocytes (TEMs), 102 Tissue engineering, 21 Titania (Ti 0.8 7O 2 ), 12 Titania films, 12 Titanium oxide, 2 Ti vacancies, 12 TLR. See Toll-like receptors (TLRs) TLR7/8 agonists, 86 TLR3 role in cross-presentation and induction of, 86 TLRs. See Toll-like receptors (TLRs) TMC. See N-Trimethyl chitosan (TMC) TNF. See Tumor necrosis factor (TNF) TNFR2 (+) Treg subpopulation, 250 Toll-like receptor 9 (TLR9), 246 Toll-like receptors (TLRs), 85, 99, 208, 360, 401 Transition metal dichalcogenides (TMDC), 12-13 Transmission electron microscopy (TEM), 158 Tregs. See T regulatory cells (Tregs) T regulatory cells (Tregs), 100 Trichoplusia ni (Tn5) insect cells, 321 Triglycerides, 250 N-Trimethyl chitosan-poly(\u03b3-glutamic acid), 289 TT. See Tetanus toxoid (TT) Tumor-associated antigens (TAAs), 207 Tumor-associated macrophages (TAMs), 102 Tumor necrosis factor (TNF), 101 Tumor necrosis factor receptor 2 (TNFR2), 250 Tunicamycin, 306 Two-dimensional nanostructures, 11 graphene, 11 inorganic nanofilms, 12 thin film optical filters, 11 transition metal dichalcogenides (TMDC), 12 Type 1 T helper cells (Th1), 402 Type 2 T helper cells (Th2), 402 size issues of particle-based, 153 traditional microbial, 150 Vaccine adjuvants. See Adjuvants Vaccine administration routes intramuscular (i.m.) injection, 327 subcutaneous (s.c.) injection, 327 Vagina associated lymphoid tissue (VALT), 359 VA-MENGOC-BC vaccine, 232 Vapor-liquid-solid (VLS) chemical vapor deposition, 3 Vascular endothelial growth factor (VEGF), 102 VEGF. See Vascular endothelial growth factor (VEGF) Vesosomes, 229 Viral hepatitis, 303 Viral-specific antibodies, 171 Virosomes, 88, 228, 241, 260, 262 Virus-like nanoparticles (NPs), 241 Virus-like particles (VLPs), 87, 127, 205, 262, 292, vaccine epitope carriers, 311-312 vaccines, computational design of, 210 vaccines, in human clinical use, 209 VLP HPV vaccine development, 418 anogenital warts incidence, 418 clinical trials, 418 herd effects, 418 Viscosity, 293 VLPs. See Virus-like particles (VLPs) Waterborne jaundice, 304 Water-in-mineral-oil emulsions, 130 Water-in-oil emulsions, 172 West Nile virus, 335 World Health Organization (WHO), 47 Wrinkle-or stain-resistant clothes, 21Xanthan gum, 294 X-ray coherent sources, 4 X-ray photoelectron spectroscopy, 307Zeolites, 2 Zero-dimensional nanostructures, 6 Zeta-potentials, 244",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}